Castor

company

About

Castor offers a cloud-based clinical data platform that simplifies and streamlines clinical trials processes.

  • 101 - 250

Details

Last Funding Type
Series A
Last Funding Money Raised
$12M
Industries
Clinical Trials,Health Care,Medical,Pharmaceutical,Software,Therapeutics
Founded date
Jan 1, 2012
Number Of Employee
101 - 250
Operating Status
Active

Castor is an international health-tech company founded by CEO Derk Arts, MD, Ph.D. Their cloud-based clinical data platform simplifies the entire clinical trial process, from recruitment to analysis, for researchers worldwide. More than 50,000 researchers across 90 countries are using Castor to supercharge their research. Castor’s platform has supported more than 4,000 commercial and academic studies that cover a broad range of therapeutic areas including diabetes, cardiovascular disease, rare diseases, infectious diseases, and oncology. Researchers on the platform generate vast amounts of data from traditional and remote trials, and Castor recently reached milestones of 180,000,000 data points and 2,000,000 enrolled patients. Castor’s goal is to make the world’s research data reusable, enabling AI-driven clinical trials, and ultimately creating a future in which they maximize the impact of data through reuse.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$12M
Castor has raised a total of $12M in funding over 2 rounds. Their latest funding was raised on Aug 19, 2020 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 19, 2020 Series A $12M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Castor is funded by 1 investors. Hambrecht Healthcare Growth Venture Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Hambrecht Healthcare Growth Venture Fund Series A